AbbVie hepatitis C drug cures 97% in transplant patient study

AbbVie’s hepatitis C treatment cured 97 percent of patients who had received a liver transplant, a study showed today, potentially adding a valuable option for a group that’s highly vulnerable to the disease. http://ift.tt/1EqF0Um
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: